ConductScience.org, home

Paper · 23040887

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42367766Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases.Front Immunol2026https://conductscience.org/library/papers/42367766PubMed
42095000Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HES.J Allergy Clin Immunol Glob2026https://conductscience.org/library/papers/42095000PubMed
41322417Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence.Front Immunol2025https://conductscience.org/library/papers/41322417PubMed
40943043Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review.Int J Mol Sci2025https://conductscience.org/library/papers/40943043PubMed
40486501Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes.Front Allergy2025https://conductscience.org/library/papers/40486501PubMed
40296395Improving patient outcomes: Mepolizumab's impact in IL-5-mediated diseases.Lung India2025https://conductscience.org/library/papers/40296395PubMed
40120806Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome.J Allergy Clin Immunol Pract2025https://conductscience.org/library/papers/40120806PubMed
39666063Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study.J Neurol2024https://conductscience.org/library/papers/39666063PubMed
39574910Updated insights into adverse events associated with mepolizumab: a disproportionality analysis from the FDA adverse event reporting system database.Front Med (Lausanne)2024https://conductscience.org/library/papers/39574910PubMed
39389908Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.Br J Haematol2024https://conductscience.org/library/papers/39389908PubMed
39389714Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis.Immunol Allergy Clin North Am2024https://conductscience.org/library/papers/39389714PubMed
39234416Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis.J Allergy Clin Immunol Glob2024https://conductscience.org/library/papers/39234416PubMed
38966441Hypereosinophilia and Left Ventricular Thrombus: A Case Report and Literature Review.Cureus2024https://conductscience.org/library/papers/38966441PubMed
37886027GEMA 5.3. Spanish Guideline on the Management of Asthma.Open Respir Arch2023https://conductscience.org/library/papers/37886027PubMed
37648281Idiopathic hypereosinophilic syndrome presenting as cardiac tamponade and multiorgan dysfunction.BMJ Case Rep2023https://conductscience.org/library/papers/37648281PubMed
37419574HES and EGPA: Two Sides of the Same Coin.Mayo Clin Proc2023https://conductscience.org/library/papers/37419574PubMed
37266434Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach.Front Immunol2023https://conductscience.org/library/papers/37266434PubMed
37259416Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37259416PubMed
37122022French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.Orphanet J Rare Dis2023https://conductscience.org/library/papers/37122022PubMed
37064032Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.Front Med (Lausanne)2023https://conductscience.org/library/papers/37064032PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/23040887/cited_by